People · Operator
Named in public records as an officer, director or promoter · active 2010–2025 · Biotechnology, Computers
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| bluebird bio, Inc. | — | Biotechnology | Series C | $187.5M | $1.9B | 2010 |
| Synlogic, Inc. | — | Biotechnology | Series C | $186.5M | $3.3B | 2017 |
| 2seventy bio, Inc. | — | Biotechnology | Series D+ | $170.0M | $4.0B | 2022 |
| Proclara Biosciences, Inc. | — | Biotechnology | Series C | $76.8M | $283.6M | 2016 |
| Edison Scientific, Inc. | — | Computers | Series C | $65.9M | $417.6M | 2025 |
Nick Leschly at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nick Leschly on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William R. Sellers | 2 | 2 |
| Denice R. Torres | 2 | 2 |
| Jeff Huber | 1 | 75 |
| Steven Gillis | 1 | 23 |
| Peter Barrett | 1 | 18 |
| Michael Powell | 1 | 14 |
| Corey Goodman | 1 | 13 |
| Edward Mathers | 1 | 12 |
| Ed Mathers | 1 | 11 |
| Chau Khuong | 1 | 9 |
| Andrew White | 1 | 8 |
| Robert Tepper | 1 | 7 |
| Daniel Lynch | 1 | 7 |
| Lewis Geffen | 1 | 6 |
| Daniel S. Lynch | 1 | 6 |
| Elaine Jones | 1 | 6 |
| Vicki Sato | 1 | 6 |
| Daniel Geffken | 1 | 6 |
| Evan S. Melrose | 1 | 5 |
| Paul Miller | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.